When a transfer cycle ends without a positive pregnancy test, or when a pregnancy is never confirmed despite an embryo being placed in the uterus, it raises a question that can feel frustratingly without an easy answer: why did the embryo not implant? Implantation failure is one of the most complex and least fully understood aspects of reproductive medicine, but that does not mean it is a dead end. It means the evaluation needs to be thorough.
Understanding implantation, what it requires, what can disrupt it, and how those disruptions can be identified is the foundation of a more targeted approach to recurrent implantation failure.
What Is Implantation?
Implantation is the process by which a developing embryo attaches to, invades, and establishes a connection with the uterine lining (endometrium). It is a highly coordinated biological event that requires three things to work simultaneously: a viable embryo capable of further development, a receptive endometrium prepared to accept the embryo, and a synchronized timing between the two.
When any one of these elements is absent or impaired, implantation fails. The embryo may degrade without attaching, or it may briefly attach and then fail to develop further. The clinical result, a negative or very briefly positive pregnancy test, is the same, but the underlying cause may be entirely different.
Embryo-Related Causes of Implantation Failure
The embryo itself is the most common source of implantation failure. Chromosomally abnormal embryos, those with too many or too few chromosomes, fail to implant or implant briefly and then result in very early loss in the vast majority of cases. This is the primary reason that preimplantation genetic testing for aneuploidy (PGT-A) can significantly reduce implantation failure rates in patients for whom chromosomal abnormality is the dominant factor.
Cytoplasmic quality, the internal machinery of the egg cell, also influences embryo viability in ways that are not captured by chromosomal testing alone. Eggs with cytoplasmic dysfunction may produce embryos that appear normal on testing but fail to sustain development after implantation. This is an area of active research and limited clinical intervention at present.
Uterine and Endometrial Causes
Structural Abnormalities
The uterus must have a normal cavity for an embryo to implant successfully. Submucosal fibroids (fibroids protruding into the uterine cavity), endometrial polyps, uterine septums, and intrauterine adhesions (Asherman's syndrome) can all interfere with implantation. Many of these can be identified on transvaginal ultrasound, saline infusion sonography, or hysteroscopy, and in many cases, surgically corrected.
At Hanabusa IVF, uterine evaluation is a standard part of the workup for patients with recurrent implantation failure. A fertility hysteroscopy allows direct visualization of the uterine cavity and can both diagnose and treat many structural abnormalities in a single procedure.
Endometrial Receptivity
Even when the uterine anatomy is normal, the endometrium must be receptive, biologically ready to accept an embryo, at the time of transfer. Receptivity is governed by a precisely timed sequence of molecular and cellular changes in the endometrial lining. When this timing window shifts relative to the transfer timing, even a chromosomally normal embryo may arrive in a lining that is not yet, or no longer, receptive.
The Endometrial Receptivity Analysis (ERA) test is a biopsy-based test that samples endometrial tissue and analyzes gene expression to determine whether the lining is in its receptive window at the time of biopsy. If the lining is found to be pre-receptive or post-receptive, the transfer timing in the next cycle can be adjusted accordingly. ERA is not appropriate for every patient, but for patients with unexplained recurrent implantation failure despite chromosomally normal embryos, it is worth discussion.
Thin Endometrial Lining
A thin endometrial lining (typically defined as less than 7mm on ultrasound) is associated with lower implantation rates. Causes of thin lining include prior uterine procedures, inadequate estrogen response, or poor blood flow to the endometrium. Treatment options depend on the cause and may include extended estrogen priming, endometrial scratch procedures, or PRP (platelet-rich plasma) protocols, though evidence for some of these interventions remains limited.
Immunological and Inflammatory Factors
The immune system plays a complex role in early pregnancy. Implantation requires a precisely calibrated immune tolerance; the uterine immune environment must accept the embryo (which is genetically foreign, since it carries the father's DNA) while still maintaining normal immune function. When this balance is disrupted, implantation can fail.
Specific immunological factors associated with implantation failure include natural killer cell dysregulation, antiphospholipid antibodies (which affect blood clotting and placental blood flow), and inflammatory cytokine imbalances. Testing for some of these factors is available, though the evidence for specific immunological treatments varies considerably. At Hanabusa IVF, immunological evaluation and treatment decisions are grounded in what the current evidence supports, not in protocols that go beyond the evidence without justification.
"The immunology of implantation is genuinely complex, and I want to be careful about the difference between what we know and what we are still learning. I evaluate relevant immune factors for patients with recurrent implantation failure, but I am honest about where the evidence is strong and where it is still emerging."
— Dr. Lyndon Chang, Medical Director at Hanabusa IVF
Thrombophilias and Clotting Factors
Blood clotting abnormalities, including antiphospholipid syndrome and inherited thrombophilias, can impair the blood vessel formation required for the early placenta to develop. For patients with confirmed thrombophilic conditions, anticoagulant therapy during early pregnancy has evidence supporting its use in reducing implantation failure and early pregnancy loss rates.
The Diagnostic Approach at Hanabusa IVF
For patients with recurrent implantation failure, typically defined as two or more failed transfers of good-quality or chromosomally normal embryos, the evaluation at Hanabusa IVF typically includes:
- Uterine cavity evaluation (hysteroscopy, SIS, or transvaginal ultrasound)
- Endometrial receptivity assessment (ERA, if appropriate)
- Thrombophilia and antiphospholipid testing
- Immunological evaluation (selected factors based on history)
- Thyroid and hormonal panel
- Sperm DNA fragmentation (if fertilization patterns suggest a sperm factor)
The evaluation is not a standard checklist applied to everyone; it is calibrated to the patient's history, prior cycle data, and clinical presentation.
"When a patient comes to me after two or three failed transfers with what appeared to be good embryos, the question I take most seriously is: what are we missing? There is usually something worth looking at more closely. Finding it, or ruling it out systematically, is the work."
— Dr. Diana LeBlanc, a Fertility Specialist at Hanabusa IVF
Frequently Asked Questions
What causes an embryo not to implant?
The most common cause is chromosomal abnormality in the embryo. When the embryo is chromosomally normal, causes include uterine structural problems, inadequate endometrial preparation, a receptivity window mismatch, immunological factors, or thrombophilias. In some cases, no single cause is identified despite a thorough evaluation.
What is recurrent implantation failure?
Recurrent implantation failure is typically defined as two or more failed transfers of good-quality or chromosomally tested normal embryos, without achieving a clinical pregnancy. It triggers a more thorough evaluation to identify potential contributing factors before additional cycles.
What is the ERA test and who should consider it?
The ERA (Endometrial Receptivity Analysis) is a biopsy-based test that evaluates whether the endometrium is in its optimal receptive window during a mock transfer cycle. It is most useful for patients with unexplained recurrent implantation failure despite chromosomally normal embryo transfers. It is not recommended for first-cycle patients or those whose implantation failure has other identifiable causes.
Can a thin uterine lining cause implantation failure?
Yes. A lining thinner than approximately 7mm is associated with lower implantation rates. If thin lining is identified during cycle monitoring, the cycle may be cancelled and alternative approaches discussed. Causes of thin lining are varied, and the treatment depends on the underlying reason.
Does PGT-A testing prevent implantation failure?
PGT-A reduces implantation failure caused by chromosomal abnormality, which is the most common cause. It does not address uterine, immunological, or receptivity-related causes. For patients with chromosomally normal embryo failures, PGT-A has already been addressed, and evaluation turns to other factors.
Moving Beyond Unexplained Failure
Implantation failure, particularly when it is recurrent, deserves a systematic, thoughtful investigation. At Hanabusa IVF, patients with recurrent implantation failure receive a complete evaluation designed to identify what can be found, treat what can be treated, and approach what remains uncertain with intellectual honesty.
If you have experienced failed transfers and want an individualized assessment of what might be contributing and what can be done differently, a consultation at Hanabusa IVF is the right starting point.
